01/18/2026
We are proud to announce that our full patent for the Neuroclear Propark device has been accepted by the United States Patent and Trademark Office!
A major milestone that puts MindMend closer to tracking the internal progression of Parkinson's Disease which will lead to faster and more reliable research and treatment.